| Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis J Grove, AK Daly, MF Bassendine, CP Day Hepatology 26 (1), 143-146, 1997 | 390 | 1997 |
| Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C BC Smith, J Grove, MA Guzail, CP Day, AK Daly, AD Burt, MF Bassendine Hepatology 27 (6), 1695-1699, 1998 | 254 | 1998 |
| Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease J Grove, AK Daly, MF Bassendine, E Gilvarry, CP Day Gut 46 (4), 540-545, 2000 | 252 | 2000 |
| ADAPT: an algorithm incorporating PRO‐C3 accurately identifies patients with NAFLD and advanced fibrosis SJ Daniels, DJ Leeming, M Eslam, AM Hashem, MJ Nielsen, A Krag, ... Hepatology 69 (3), 1075-1086, 2019 | 225 | 2019 |
| Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study P Nicoletti, GP Aithal, ES Bjornsson, RJ Andrade, A Sawle, M Arrese, ... Gastroenterology 152 (5), 1078-1089, 2017 | 224 | 2017 |
| A seven‐gene operon essential for formate‐dependent nitrite reduction to ammonia by enteric bacteria H Hussain, J Grove, L Griffiths, S Busby, J Cole Molecular microbiology 12 (1), 153-163, 1994 | 199 | 1994 |
| Escherichia coli K‐12 genes essential for the synthesis of c‐type cytochromes and a third nitrate reductase located in the periplasm J Grove, S Tanapongpipat, G Thomas, L Griffiths, H Crooke, J Cole Molecular microbiology 19 (3), 467-481, 1996 | 198 | 1996 |
| Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance CP Day, J Grove, AK Daly, MW Stewart, PJ Avery, M Walker Diabetologia 41, 430-434, 1998 | 184 | 1998 |
| Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis S Astbury, E Atallah, A Vijay, GP Aithal, JI Grove, AM Valdes Gut microbes 11 (3), 569-580, 2020 | 160 | 2020 |
| Nitroreductase: a prodrug-activating enzyme for cancer gene therapy. PF Searle, MJ Chen, L Hu, PR Race, AL Lovering, JI Grove, C Guise, ... Clinical & Experimental Pharmacology & Physiology 31 (11), 2004 | 145 | 2004 |
| Regulation and sequence of the structural gene for cytochrome C552 from Escherichia coli: not a hexahaem but a 50kDa tetrahaem nitrite reductase A Darwin, H Hussain, L Griffiths, J Grove, Y Sambongi, S Busby, J Cole Molecular microbiology 9 (6), 1255-1265, 1993 | 139 | 1993 |
| RecN protein and transcription factor DksA combine to promote faithful recombinational repair of DNA double‐strand breaks TR Meddows, AP Savory, JI Grove, T Moore, RG Lloyd Molecular microbiology 57 (1), 97-110, 2005 | 136 | 2005 |
| Association of the tumour necrosis factor α− 308 but not the interleukin 10− 627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis SA Mitchell, J Grove, A Spurkland, KM Boberg, KA Fleming, CP Day, ... Gut 49 (2), 288-294, 2001 | 134 | 2001 |
| Detection and characterization of novel polymorphisms in the CYP2E1 gene KS Fairbrother, J Grove, I de Waziers, DT Steimel, CP Day, CL Crespi, ... Pharmacogenetics and Genomics 8 (6), 543-552, 1998 | 131 | 1998 |
| The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype J Grove, AK Daly, MF Bassendine, OFW James, CP Day, ASJM Brown Pharmacogenetics and Genomics 8 (4), 335-342, 1998 | 122 | 1998 |
| Involvement of products of the nrfEFG genes in the covalent attachment of haem c to a novel cysteine–lysine motif in the cytochrome c552 nitrite reductase from Escherichia coli DJ Eaves, J Grove, W Staudenmann, P James, RK Poole, SA White, ... Molecular microbiology 28 (1), 205-216, 1998 | 122 | 1998 |
| Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers F Stickel, P Lutz, S Buch, HD Nischalke, I Silva, V Rausch, J Fischer, ... Hepatology 72 (1), 88-102, 2020 | 106 | 2020 |
| Tumour necrosis factor-a promoter polymorphisms in primary biliary cirrhosis DEJ Jones, FE Watt, J Grove, JL Newton, AK Daly, WL Gregory, CP Day, ... Journal of hepatology 30 (2), 232-236, 1999 | 105 | 1999 |
| A reassessment of the range of c-type cytochromes synthesized by Escherichia coli K-12 C Iobbi-Nivol, H Crooke, L Griffiths, J Grove, H Hussain, J Pommier, ... FEMS microbiology letters 119 (1-2), 89-94, 1994 | 105 | 1994 |
| Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease J Grove, AK Daly, AD Burt, M Guzail, OFW James, MF Bassendine, ... Gut 43 (2), 262-266, 1998 | 104 | 1998 |
